Press Releases - 2021-08-11

Date	Title	Company
11-Aug-2021	Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market 2021 Growth, Trends, Leading Players, and Business Insights Forecast to 2026	CDN Newswire
11-Aug-2021	NICE RECOMMENDS KITE’S TECARTUS®▼ FOR THE TREATMENT OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA (MCL) AFTER TWO OR MORE LINES OF SYSTEMIC THERAPY INCLUDING A BRUTON’S TYROSINE KINASE (BTK) INHIBITOR IN ENGLAND WITHIN THE CANCER DRUGS FUND	Kite
11-Aug-2021	Melanoma Cancer Diagnostics Market is expected to register CAGR of 4.7% by the end of 2028	MARKITWIRED Latest Market Reports
11-Aug-2021	Polyplus launches FectoVIR(R)-AAV GMP transfection reagent for large scale viral vector production to overcome commercial gene and cell therapy manufacturing barriers	Polyplus
11-Aug-2021	Nouscom highlights innovative science behind VENUS, its novel algorithm for identifying and prioritizing patient-specific tumor neoantigens for personalized cancer immunotherapy	Nouscom
11-Aug-2021	GW Pharmaceuticals receives approval for EPIDYOLEX® (cannabidiol) from the MHRA for the treatment of seizures associated with tuberous sclerosis complex	GW Pharmaceuticals
11-Aug-2021	Santen and Sydnexis execute an exclusive licensing agreement for SYD-101, a novel investigational treatment for progressive childhood myopia	Santen and Sydnexis
11-Aug-2021	Subscription to raise £1,000,000 to progress proprietary TYK2/JAK1 programmes into clinical development	Sareum Holdings plc
11-Aug-2021	FORXIGA (dapagliflozin) APPROVED IN GREAT BRITAIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE	AstraZeneca
11-Aug-2021	Spectral MD hosts event to launch a multi-center clinical study for burn wounds	Spectral MD Holdings, Ltd
11-Aug-2021	Forxiga approved in the EU for the treatment of chronic kidney disease in patients with and without type-2 diabetes	AstraZeneca
11-Aug-2021	Just - Evotec Biologics opens J.POD® 1 US in Redmond, Washington	Evotec
11-Aug-2021	Medical Cannabis Market Size, Share, Trends, Regional Analysis, Segments, Revenue, Demand, Future Plans and Opportunities To 2028	The Wire Times
11-Aug-2021	HUTCHMED and Epizyme Announce Strategic Collaboration to Develop and Commercialize TAZVERIK® (tazemetostat) in Greater China	HUTCHMED
11-Aug-2021	New Two-Year Data Showed Bimekizumab Maintained High Levels of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis	UCB
11-Aug-2021	North America to Remain the Most Lucrative Market for Speech Generating Devices, Reveals Fact.MR	MARKITWIRED Latest Market Reports
11-Aug-2021	FDA approves Nexviazyme® (avalglucosidase alfa-ngpt), an important new treatment option for late-onset Pompe disease	Sanofi
11-Aug-2021	Bio-Thera Solutions Reported the Discovery of a Broad-Spectrum SARS-CoV-2 Neutralizing Antibody with Potential to Treat Many Known Variants of COVID-19	Businesswire
11-Aug-2021	Global Polycystic Ovarian Syndrome Treatment Market Comprehensive Research Study, Industry Size, Production Development and Opportunities 2021 to 2026	CDN Newswire
11-Aug-2021	Rise of New Demography for Anti-aging Serums ,Owing to the Care of the Texture of Skin	MARKITWIRED Latest Market Reports